PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 193 filers reported holding PDL BIOPHARMA INC in Q4 2016. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $1,050,000 | -57.8% | 334,538 | -50.0% | 0.06% | -58.8% |
Q1 2019 | $2,488,000 | +11.2% | 669,076 | -13.3% | 0.14% | +7.1% |
Q4 2018 | $2,238,000 | +80.5% | 771,644 | +63.6% | 0.13% | +115.3% |
Q3 2018 | $1,240,000 | +111.6% | 471,644 | +88.7% | 0.06% | +43.9% |
Q2 2018 | $586,000 | -20.4% | 250,000 | 0.0% | 0.04% | -18.0% |
Q1 2018 | $736,000 | +7.3% | 250,000 | 0.0% | 0.05% | +8.7% |
Q4 2017 | $686,000 | -27.8% | 250,000 | -10.7% | 0.05% | +1433.3% |
Q3 2017 | $950,000 | +666.1% | 280,000 | +460.0% | 0.00% | – |
Q2 2017 | $124,000 | +8.8% | 50,000 | 0.0% | 0.00% | – |
Q1 2017 | $114,000 | +44.3% | 50,000 | +34.9% | 0.00% | – |
Q4 2016 | $79,000 | -98.4% | 37,058 | -94.0% | 0.00% | -100.0% |
Q3 2013 | $4,923,000 | – | 617,659 | -31.2% | 0.02% | – |
Q2 2013 | $0 | – | 897,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Argent Trust Co | 41,405 | $102,270 | 0.01% |
Diversified Trust Co | 11,029 | $26,469 | 0.00% |
HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
Ancora Advisors LLC | 4,948 | $0 | 0.00% |
Westside Investment Management, Inc. | 500 | $0 | 0.00% |